Injective vs Raydium Staking
Side-by-side comparison of INJ and RAY staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs Raydium: which should you stake?
Raydium currently offers the higher APY at 12.00% compared to Injective's 7.40%. That's a 4.60 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $486.44M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs Raydium — common questions
Is Injective or Raydium better for staking?
Raydium currently offers a higher staking APY at 12.00% compared to Injective's 7.40%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and Raydium?
Injective offers 7.40% APY while Raydium offers 12.00% APY — a difference of 4.60 percentage points.
Which is safer to stake: INJ or RAY?
Injective has a medium risk rating while Raydium has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and RAY?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and Raydium spreads your risk across different networks and protocols.